1335 related articles for article (PubMed ID: 16516908)
1. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
2. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.
Zvirbliene A; Kucinskaite-Kodze I; Razanskiene A; Petraityte-Burneikiene R; Klempa B; Ulrich RG; Gedvilaite A
Viruses; 2014 Feb; 6(2):640-60. PubMed ID: 24513568
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
[TBL] [Abstract][Full Text] [Related]
4. Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination.
Neugebauer M; Walders B; Brinkman M; Ruehland C; Schumacher T; Bertling WM; Geuther E; Reiser CO; Reichel C; Strich S; Hess J
Biotechnol J; 2006 Dec; 1(12):1435-46. PubMed ID: 17109492
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
7. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
8. Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells.
Gedvilaite A; Dorn DC; Sasnauskas K; Pecher G; Bulavaite A; Lawatscheck R; Staniulis J; Dalianis T; Ramqvist T; Schönrich G; Raftery MJ; Ulrich R
Virology; 2006 Oct; 354(2):252-60. PubMed ID: 16904154
[TBL] [Abstract][Full Text] [Related]
9. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice.
Gedvilaite A; Zvirbliene A; Staniulis J; Sasnauskas K; Krüger DH; Ulrich R
Viral Immunol; 2004; 17(1):51-68. PubMed ID: 15018662
[TBL] [Abstract][Full Text] [Related]
10. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.
Shahhosseini S; Das D; Qiu X; Feldmann H; Jones SM; Suresh MR
J Virol Methods; 2007 Jul; 143(1):29-37. PubMed ID: 17368819
[TBL] [Abstract][Full Text] [Related]
12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
13. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
[TBL] [Abstract][Full Text] [Related]
14. Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration.
Fric J; Marek M; Hrusková V; Holán V; Forstová J
Vaccine; 2008 Jun; 26(26):3242-51. PubMed ID: 18468739
[TBL] [Abstract][Full Text] [Related]
15. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
16. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
[TBL] [Abstract][Full Text] [Related]
17. A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors.
Tegerstedt K; Lindencrona JA; Curcio C; Andreasson K; Tullus C; Forni G; Dalianis T; Kiessling R; Ramqvist T
Cancer Res; 2005 Jul; 65(13):5953-7. PubMed ID: 15994974
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies specific for major capsid VP1 protein of trichodysplasia spinulosa-associated polyomavirus.
Khatun H; Yamaoka Y; Matsushima Y; Matsunaga S; Kimura H; Ho J; Shuda M; Ryo A
Microbiol Immunol; 2018 Dec; 62(12):763-773. PubMed ID: 30537287
[TBL] [Abstract][Full Text] [Related]
19. Chimeric polyomavirus-derived virus-like particles: the immunogenicity of an inserted peptide applied without adjuvant to mice depends on its insertion site and its flanking linker sequence.
Lawatscheck R; Aleksaite E; Schenk JA; Micheel B; Jandrig B; Holland G; Sasnauskas K; Gedvilaite A; Ulrich RG
Viral Immunol; 2007 Sep; 20(3):453-60. PubMed ID: 17931115
[TBL] [Abstract][Full Text] [Related]
20. HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.
Ludmerer SW; McClements WL; Wang XM; Ling JC; Jansen KU; Christensen ND
Virology; 2000 Jan; 266(2):237-45. PubMed ID: 10639310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
